Showing results (11-20 of 402) with videos related to
Sort By:
Pageof 41
Clinical Pharmacokinetics|November 1, 1996
Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsJ P Desager, Y HorsmansClinical Pharmacokinetics|May 1, 1995
Pharmacokinetic-pharmacodynamic relationships of H1-antihistaminesJ P Desager, Y HorsmansRevue Des Maladies Respiratoires|May 7, 2021
[New developments in the management of hypersensitivity pneumonitis]L Michaux, A FroidureActa Gastro-Enterologica Belgica|May 1, 1994
[Chronic viral hepatitis and interferons: preliminary results in 60 patients with chronic hepatitis C and cellular mechanism of action]R Brenard, Y Horsmans, A GeubelClinical Nephrology|March 23, 2006
Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infectionN Kanaan, Y Horsmans, E GoffinLiver|April 1, 1991
Reversible cholestasis with bile duct injury following azathioprine therapy. A case reportY Horsmans, J Rahier, A P GeubelPharmacology & Toxicology|March 23, 2000
Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced ratsM Spatzenegger, Y Horsmans, R K VerbeeckJournal of Clinical Pharmacology|May 1, 1992
Effects of combined bezafibrate-simvastatin appraised in healthy subjectsY Horsmans, J P Desager, C HarvengtJournal De Radiologie|July 5, 2003
[Multidetector CT and MRI of benign liver tumors]Be Van Beers, Y Horsmans, C SempouxClinical Pharmacology and Therapeutics|September 5, 1998
Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercressI Leclercq, J P Desager, Y HorsmansPageof 41